MRK
Merck·NYSE
--
--(--)
--
--(--)
MRK fundamentals
Merck (MRK) Revenue Breakdown: Q4 2025 Business & Regional Performance
Merck (MRK) reported total revenue of 16.40B USD in Q4 2025, with its core business segment Pharmaceutical contributing 90.51%. Regionally, United States remained the largest market, accounting for 57.95% of total revenue. Explore Merck's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Merck (MRK) reported total revenue of 16.40B USD in Q4 2025, with its core business segment Pharmaceutical contributing 90.51%. Regionally, United States remained the largest market, accounting for 57.95% of total revenue. Explore Merck's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Merck's earnings call?Did Merck beat or miss consensus estimates last quarter?What guidance did Merck's management provide for the next earnings period?What is the market's earnings forecast for Merck next quarter?What is the revenue and EPS growth rate for Merck year over year?What does Merck do and what are its main business segments?What were the key takeaways from Merck’s earnings call?What factors drove the changes in Merck's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
